Mankind Pharma’s Q1FY25 consolidated net profit surges by 10%

31 Jul 2024 Evaluate

Mankind Pharma has reported results for first quarter ended June 30, 2024 (Q1FY25). 

The company has reported 25.46% rise in net profit at Rs 513.49 crore for Q1FY25 as compared to Rs 409.28 crore for the same quarter in the previous year. Total income of the company increased by 16.21% at Rs 2,498.09 crore for Q1FY25 as compared to Rs 2,149.72 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 9.89% rise in its net profit at Rs 543.07 crore for the quarter ended June 30, 2024 as compared to Rs 494.19 crore for the same quarter in the previous year. Total income of the company increased by 13.53% at Rs 2,994.02 crore for Q1FY25 as compared to Rs 2,637.24 crore for the corresponding quarter previous year.


Mankind Pharma Share Price

2803.45 -86.00 (-2.98%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.